Brainstorm Cell Therapeutics | BCLI - Pre Tax Profit


Brainstorm Cell Therapeutics reported $-2.11M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -6.26M 1.52M Dec/2025
Biogen USD 647.3M 269.6M Jun/2026
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Cipla INR 10.82B 3.33B Jun/2026
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD -7.66M 64.51M Mar/2026
CSL USD 2.61B 1.21B Dec/2025
Cytokinetics USD -206.03M 23M Mar/2026
Gilead Sciences USD -7.53B 10.11B Jun/2026
Grifols EUR 257.85M 190.87M Dec/2024
Halozyme Therapeutics USD 180.33M 281.18M Mar/2026
Mesoblast USD 39.72M 93.81M Dec/2025